X

Trial Profile

Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ACE inhibitors; Aspirin; Beta-adrenergic receptor antagonists; Cardiovascular therapies
Indications Embolism and thrombosis; Myocardial infarction
Focus Therapeutic Use
Acronyms OAT

Most Recent Events

21 Apr 2014 Biomarkers information updated
01 Apr 2009 Results of a subgroup analysis published in the American Heart Journal.
19 Feb 2009 Results of a quality-of-life analysis and economic substudy were published in New England Journal of Medicine 360: 774-783, No. 8.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com